SCHEMBL5218509

SCHEMBL5218509

OB(O)CCCCCCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28414171 1.00 ANPEP (0.43)
SCHEMBL28421415 0.87
SCHEMBL28463686 0.83 ANPEP (0.56)
SCHEMBL28462261 0.83 ANPEP (0.56)
SCHEMBL28464463 0.83 ANPEP (0.56)
SCHEMBL28960012 0.83 ANPEP (0.56)
SCHEMBL28466591 0.83 ANPEP (0.56)
SCHEMBL17492163 0.83 ANPEP (0.56)
SCHEMBL28457949 0.83 ANPEP (0.56)
SCHEMBL28456663 0.83 ANPEP (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109912518-B Method for synthesizing dibenzo [ f, h ] quinoxaline, dibenzo [ f, h ] quinoxaline derivative, and light-emitting device 株式会社半导体能源研究所 2022-10-14 CN disclosed
EP-1869041-A1 TETRAHYDRO-PYRIDOAZEPIN-8-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA Warner-Lambert Company LLC (US) 2007-12-26 EP disclosed
US-20060234997-A1 Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia WARNER-LAMBERT COMPANY LLC 2006-10-19 US disclosed
WO-2006103559-A1 TETRAHYDRO-PYRIDOAZEPIN-8-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA WARNER-LAMBERT COMPANY LLC (US) 2006-10-05 WO disclosed
US-5262556-A Alkylation or hydroxyalkylation by deprotonation MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1993-11-16 US disclosed